Cosmos Health (NASDAQ: COSM) CEO swaps $57,000 debt for 113,185 shares

Rhea-AI Filing Summary

Cosmos Health Inc. insider filing shows its CEO and 10% owner, Grigorios Siokas, acquiring 113,185 shares of common stock on January 12, 2026. The shares were obtained at $0.5036 per share under a Debt Exchange Agreement, using $57,000 of debt the company owed to him as payment instead of cash. After this transaction, he beneficially owns 7,244,979 common shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	01/12/2026	01/12/2026	P(1)		113,185	A	$0.5036	7,244,979	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of January 12, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.5036 per share, the fair market value of the Common Stock on January 12, 2026, in exchange for a total amount of $57,000 in debt the Company owed to Mr. Siokas.

Remarks:

	/s/ Grigorios Siokas	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did COSM report in this Form 4?

The filing reports that CEO and 10% owner Grigorios Siokas acquired 113,185 shares of Cosmos Health Inc. common stock on January 12, 2026.

At what price were the new Cosmos Health (COSM) shares acquired?

The 113,185 shares were acquired at $0.5036 per share, described as the fair market value of the common stock on January 12, 2026.

How was the COSM insider share acquisition funded?

The shares were issued under a Debt Exchange Agreement, in exchange for $57,000 of debt that Cosmos Health owed to Grigorios Siokas, instead of paying that amount in cash.

How many Cosmos Health shares does the CEO own after this transaction?

Following the reported transaction, Grigorios Siokas beneficially owns 7,244,979 shares of Cosmos Health common stock in direct ownership.

What is the role of the reporting person in Cosmos Health (COSM)?

The reporting person, Grigorios Siokas, is a director, a 10% owner, and serves as Chief Executive Officer of Cosmos Health Inc.

Was this COSM insider transaction a purchase on the open market?

No. The transaction is described as acquisition of Exchange Shares under a Debt Exchange Agreement, where company debt of $57,000 owed to the CEO was exchanged for shares at $0.5036 per share.